The title compound [Cu（C11H29N5）]（ClO4）2 was synthesized and characterized by elemental analysis, IR and X-ray single-crystal diffraction. The compound crystallizes in the monoclinic system, space group P21/n with...The title compound [Cu（C11H29N5）]（ClO4）2 was synthesized and characterized by elemental analysis, IR and X-ray single-crystal diffraction. The compound crystallizes in the monoclinic system, space group P21/n with α = 9.405（2）, b = 14.495（3）, c = 14.715（3） A, β= 90.262（3）°, V=2006.1（7） A^3,M,=493.83,Z=4,F）（000）= 1028,Dc= 1.635 g/cm^3, T= 298（2） K,μ= 1.403 mm^-1 and = 0.71073 A. The was refined to R = 0.0508 and wR = 0. 1250 for 2293 observed reflections with I 〉 2σ（I）. The Cu（Ⅱ） atom possesses a five-coordtinate CuN5 environment which shows a slightly distorted square-pyramidal geonetry. Antimicrobial activity study found that the complex is active against Salmonella species, Staphylococcus aureu, Bacillus pumilus and Bacillus coliforms.展开更多
基金The project was supported by the Natural Science Foundation of Jiangsu Province (No. BK2005045) and Key Marine Biotechnology Lab. of HHIT
文摘The title compound [Cu（C11H29N5）]（ClO4）2 was synthesized and characterized by elemental analysis, IR and X-ray single-crystal diffraction. The compound crystallizes in the monoclinic system, space group P21/n with α = 9.405（2）, b = 14.495（3）, c = 14.715（3） A, β= 90.262（3）°, V=2006.1（7） A^3,M,=493.83,Z=4,F）（000）= 1028,Dc= 1.635 g/cm^3, T= 298（2） K,μ= 1.403 mm^-1 and = 0.71073 A. The was refined to R = 0.0508 and wR = 0. 1250 for 2293 observed reflections with I 〉 2σ（I）. The Cu（Ⅱ） atom possesses a five-coordtinate CuN5 environment which shows a slightly distorted square-pyramidal geonetry. Antimicrobial activity study found that the complex is active against Salmonella species, Staphylococcus aureu, Bacillus pumilus and Bacillus coliforms.
